Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongmei Bai

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cellular and Molecular Life Sciences : CMLS|March 18, 2026
Targeting lanosterol synthase alleviates MASLD by promoting fatty acid catabolismSumei Zhang, Mingcong Li, Xiaomei Sun, et al.
Nano Letters|July 19, 2021
RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2Zhongqian Yang, Liangqun Hua, Mengli Yang, et al.
ACS Nano|February 22, 2024
Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune ResponsesPeng Zheng, Jinrong He, Yuting Fu, et al.
Frontiers in Immunology|October 3, 2022
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells <i>in vivo</i> by transgenic expression of a truncated GSDMD N-terminusJinrong He, Peng Zheng, Yongjun Chen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cellular and Molecular Life Sciences : CMLS|March 18, 2026
Targeting lanosterol synthase alleviates MASLD by promoting fatty acid catabolismSumei Zhang, Mingcong Li, Xiaomei Sun, et al.
Nano Letters|July 19, 2021
RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2Zhongqian Yang, Liangqun Hua, Mengli Yang, et al.
ACS Nano|February 22, 2024
Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune ResponsesPeng Zheng, Jinrong He, Yuting Fu, et al.
Frontiers in Immunology|October 3, 2022
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells <i>in vivo</i> by transgenic expression of a truncated GSDMD N-terminusJinrong He, Peng Zheng, Yongjun Chen, et al.
Pageof 5